News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
105,108 Results
Type
Article (6335)
Company Profile (26)
Press Release (98747)
Multimedia
Podcasts (2)
Webinars (1)
Section
Business (30916)
Career Advice (199)
Deals (4782)
Drug Delivery (6)
Drug Development (8965)
Employer Resources (11)
FDA (2912)
Job Trends (2940)
News (49873)
Policy (5469)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
Academia (667)
Academic (1)
Accelerated approval (1)
Allergies (18)
Alliances (9996)
ALS (15)
Alzheimer's disease (218)
Antibody-drug conjugate (ADC) (42)
Approvals (3027)
Artificial intelligence (76)
Autoimmune disease (11)
Automation (21)
Bankruptcy (26)
Best Places to Work (2273)
BIOSECURE Act (1)
Biosimilars (10)
Biotechnology (17)
Bladder cancer (39)
Brain cancer (7)
Breast cancer (128)
Cancer (835)
Cardiovascular disease (34)
Career advice (184)
Career pathing (1)
CAR-T (37)
CDC (2)
Celiac Disease (1)
Cell therapy (84)
Cervical cancer (10)
Clinical research (7322)
Collaboration (304)
Company closure (1)
Compensation (6)
Complete response letters (5)
COVID-19 (556)
CRISPR (14)
C-suite (92)
Cystic fibrosis (12)
Data (817)
Denatured (1)
Depression (5)
Diabetes (35)
Diagnostics (3323)
Digital health (4)
Diversity (1)
Diversity, equity & inclusion (1)
Drug discovery (48)
Drug pricing (4)
Drug shortages (2)
Duchenne muscular dystrophy (17)
Earnings (9253)
Employer branding (3)
Employer resources (9)
Events (10668)
Executive appointments (140)
FDA (3302)
Fibrodysplasia Ossificans Progressiva (2)
Frontotemporal dementia (2)
Funding (159)
Gene editing (22)
Generative AI (5)
Gene therapy (70)
GLP-1 (118)
Government (913)
Grass and pollen (3)
Guidances (48)
Healthcare (2287)
HIV (11)
Huntington's disease (1)
IgA nephropathy (2)
Immunology and inflammation (11)
Immuno-oncology (4)
Indications (19)
Infectious disease (610)
Inflammatory bowel disease (11)
Influenza (28)
Intellectual property (21)
Interviews (24)
IPO (1428)
IRA (1)
Job creations (776)
Job search strategy (174)
JPM (5)
Kidney cancer (1)
Labor market (4)
Layoffs (37)
Leadership (2)
Legal (1116)
Liver cancer (11)
Lung cancer (129)
Lymphoma (73)
Machine learning (7)
Management (3)
Manufacturing (135)
MASH (8)
Medical device (1396)
Medtech (1397)
Mergers & acquisitions (3478)
Metabolic disorders (71)
Multiple sclerosis (9)
NASH (1)
Neurodegenerative disease (29)
Neuropsychiatric disorders (1)
Neuroscience (297)
NextGen: Class of 2026 (792)
Non-profit (587)
Now hiring (14)
Obesity (27)
Opinion (18)
Ovarian cancer (18)
Pain (10)
Pancreatic cancer (24)
Parkinson's disease (20)
Partnered (7)
Patents (36)
Patient recruitment (25)
Peanut (10)
People (9561)
Pharmaceutical (6)
Phase 1 (2123)
Phase 2 (2787)
Phase 3 (2884)
Pipeline (668)
Policy (7)
Postmarket research (393)
Preclinical (1220)
Press Release (18)
Prostate cancer (38)
Psychedelics (2)
Radiopharmaceuticals (33)
Rare diseases (72)
Real estate (1986)
Recruiting (4)
Regulatory (4018)
Reports (7)
Research institute (643)
Resumes & cover letters (19)
Rett syndrome (2)
RSV (9)
Schizophrenia (2)
Series A (26)
Series B (10)
Sickle cell disease (9)
Spinal muscular atrophy (37)
Sponsored (7)
Startups (609)
State (1)
Stomach cancer (2)
Supply chain (19)
Tariffs (1)
The Weekly (1)
Vaccines (74)
Venture capital (1)
Weight loss (17)
Women's health (12)
Date
Last 7 days (54)
Last 30 days (228)
Last 365 days (3260)
2026 (286)
2025 (3353)
2024 (4405)
2023 (5253)
2022 (8593)
2021 (8967)
2020 (8740)
2019 (6088)
2018 (4735)
2017 (5147)
2016 (5256)
2015 (5806)
2014 (4673)
2013 (4156)
2012 (4414)
2011 (4476)
2010 (3994)
Location
Africa (126)
Alabama (11)
Alaska (1)
Arizona (49)
Arkansas (2)
Asia (6499)
Australia (1079)
California (1146)
Canada (354)
China (61)
Colorado (65)
Connecticut (47)
Delaware (49)
Europe (14267)
Florida (166)
Georgia (18)
Idaho (6)
Illinois (81)
India (8)
Indiana (72)
Iowa (2)
Japan (60)
Kansas (25)
Kentucky (7)
Louisiana (3)
Maine (27)
Maryland (150)
Massachusetts (775)
Michigan (87)
Minnesota (46)
Missouri (60)
Montana (9)
Nebraska (3)
Nevada (8)
New Hampshire (8)
New Jersey (516)
New Mexico (8)
New York (387)
North Carolina (209)
North Dakota (1)
Northern California (482)
Ohio (61)
Oklahoma (4)
Oregon (4)
Pennsylvania (173)
Rhode Island (11)
South America (177)
South Carolina (6)
Southern California (491)
Tennessee (28)
Texas (333)
United States (4717)
Utah (74)
Virginia (17)
Washington D.C. (6)
Washington State (114)
Wisconsin (20)
105,108 Results for "galderma laboratories".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics
January 15, 2026
·
6 min read
Press Releases
Galderma Announces U.S. FDA Acceptance of RelabotulinumtoxinA Biologics License Application Resubmission
February 2, 2026
·
5 min read
Press Releases
Galderma announces the authorization of NEMLUVIO® (nemolizumab) for atopic dermatitis and prurigo nodularis in Canada
January 12, 2026
·
11 min read
Press Releases
ASDS 2025: Compelling New Data on Restylane, Sculptra and Relfydess Highlight Galderma’s Innovative Injectable Aesthetics Portfolio and Pipeline
November 17, 2025
·
13 min read
Press Releases
Galderma Announces First Patient Enrollment in Study to Assess Nemolizumab in Adults With Chronic Pruritus of Unknown Origin
December 11, 2025
·
7 min read
Press Releases
Galderma Receives U.S. FDA Approval for Restylane® Lyft™ for the Enhancement of the Chin Profile
November 5, 2025
·
9 min read
Press Releases
EADV 2025: Galderma Reinforces Leadership in Dermatology With Latest Advances in Sensitive Skin and Itch
September 11, 2025
·
9 min read
Press Releases
Galderma’s Nemluvio® (nemolizumab) Receives National Institute for Health and Care Excellence (NICE) Recommendation for Moderate-to-severe Atopic Dermatitis in England and Wales
June 12, 2025
·
9 min read
Press Releases
Galderma Delivers Record Net Sales of 3.737 Billion USD in the First Nine Months of 2025 and 15.0% Year-on-Year Growth at Constant Currency, Raises Full-Year Guidance
October 23, 2025
·
17 min read
Press Releases
Galderma Buys Back Shares Worth CHF 233 Million in the Context of Accelerated Bookbuild Offering
May 29, 2025
·
4 min read
1 of 10,511
Next
